6505--760-24-2-050-0708 -Leavenworth CMOP 15 PHARMACEUTICALS
ID: 36C77024Q0252Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNATIONAL CMOP OFFICE (36C770)LEAVENWORTH, KS, 66048, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/7ab6b92dedc24620a1b50e62703725e5/view
Timeline
    Description

    Presolicitation Notice: Veterans Affairs, Department of is seeking to procure fifteen line item pharmaceuticals for delivery to the CMOP facility in Leavenworth, KS. The pharmaceuticals include various medications such as amoxicillin, albuterol, amlodipine, ciprofloxacin, and more. The procurement is a total small business set-aside and falls under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing. The estimated issue date is 4/3/2024, and the response due date is 4/10/2024. The delivery time frame is staggered monthly, with the first delivery made 10 days after receipt of order (ARO) and two more deliveries to follow. All responsible sources may submit a quotation, and it is the offeror's responsibility to monitor SAM.GOV for changes or amendments. Vendors must provide their state wholesale distributor licensure, verifying compliance with the Drug Supply Chain Security Act (DSCSA), with their quote. The solicitation packages will be submitted via email. For more information, contact Kayla Powers at KAYLA.POWERS@VA.GOV or (913) 758-9915.

    Point(s) of Contact
    Kayla E PowersContract Specialist
    Kayla.Powers@va.gov
    Files
    Title
    Posted
    36C77024Q0252_1.docx
    36C77024Q0252.docx
    S02.Pricing Schedule_Q0252.xlsx
    Similar Opportunities
    760-25-1-050-0154 -Leavenworth CMOP THYROID TABLETS -(VA-25-00022614)
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Armour Thyroid tablets for the Leavenworth Consolidated Mail Outpatient Pharmacy (CMOP) under solicitation number 36C77025Q0079. This Request for Quotation (RFQ) emphasizes the need for specific brand-name pharmaceuticals, with a focus on compliance with federal regulations, including the Drug Supply Chain Security Act and the Buy American Act. The procurement process aims to ensure a reliable supply of essential medications for veterans, with a firm-fixed-price contract expected to be awarded based on fair market evaluations. Interested vendors must submit their quotes by December 27, 2024, at 4:00 PM CST, and can direct inquiries to Jennifer L. Knight at jennifer.knight@va.gov or by phone at 913-684-0162.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0206
    Buyer not available
    The Department of Veterans Affairs is seeking vendors to supply various dosages of Ibuprofen as part of a procurement for pharmaceuticals, specifically under solicitation number 36C77025Q0206. The requirement includes multiple quantities of Ibuprofen 400mg, 600mg, and 800mg tablets, which will be delivered to several locations within the Veterans Affairs network. This procurement is crucial for ensuring a consistent supply of essential medications for veterans, adhering to federal regulations and standards, including compliance with the Drug Supply Chain Security Act (DSCSA). Interested vendors must submit their quotes by April 24, 2025, at 09:00 AM (CST), and can contact Contract Specialist Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134 for further details.
    6505--Loperamide Capsules (VA-25-00032225)
    Buyer not available
    The Department of Veterans Affairs (VA) is seeking proposals for the procurement of Loperamide Hydrochloride (HCL) 2mg capsules, aimed at establishing a reliable supply source for pharmaceutical products to support healthcare services for veterans and other authorized users. Offerors must provide pricing for the base year and four additional one-year options, ensuring compliance with regulatory standards, including the Drug Supply Chain Security Act (DSCSA) and Good Manufacturing Practices (cGMP). This procurement is critical for maintaining the quality and safety of pharmaceutical distribution to VA facilities and the Department of Defense through a network of Prime Vendors. Proposals are due by April 23, 2025, at 2:30 PM Central Time, and interested parties should contact Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further information.
    6505--Fludrocortisone Acetate Tablets (VA-25-00047932)
    Buyer not available
    The Department of Veterans Affairs is seeking offers for the procurement of Fludrocortisone Acetate Tablets (0.1 MG) under solicitation number 36E79725R0023, with an emphasis on compliance with federal regulations and pharmaceutical standards. Contractors are required to submit bids that include pricing for a base year and four option years, adhering to guidelines such as a 0.5% Cost Recovery Fee and compliance with the Drug Supply Chain Security Act. This procurement is crucial for ensuring a reliable supply of essential pharmaceuticals for veterans, reflecting the government's commitment to maintaining high standards in healthcare delivery. The deadline for submitting offers has been extended to April 21, 2025, at 2:30 PM Central Daylight Time, and interested parties should contact Contract Specialist Nicholas I McGregor at Nicholas.McGregor@va.gov for further information.
    6505--Ranolazine Sustained Action (SA) Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Ranolazine Sustained Action (SA) Tablets, which will serve various federal entities, including the VA, Department of Defense, and Bureau of Prisons. The procurement aims to secure an uninterrupted supply of these pharmaceutical products, with specific requirements for labeling and packaging, including the necessity for a unique National Drug Code (NDC) and safety-cap standards. The estimated annual demand includes 229,028 bottles of 500 mg SA tablets and 95,925 bottles of 1000 mg SA tablets, with the contract expected to last one year, plus four optional one-year extensions. Interested offerors should monitor SAM.gov for updates and submit their proposals by May 6, 2025, with any inquiries directed to Contract Specialist Deb Fassl at Deborah.Fassl@va.gov.
    6505--Acyclovir Capsules (VA-25-00048078)
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of Acyclovir Capsules, specifically 200MG capsules in two packaging sizes, to support the healthcare needs of veterans. The solicitation includes two line items: Line Item 1 requires 3,256 bottles of 100 capsules per bottle, and Line Item 2 requests 15,475 bottles of 500 capsules per bottle, with the same quantities needed for the base year and each of the four option years. This procurement is crucial for ensuring a reliable supply of essential pharmaceuticals for veterans, emphasizing the importance of compliance and competition within the pharmaceutical supply chain. Interested suppliers must submit their pricing proposals by May 1, 2025, and can contact Contracting Officer Andrew Cazares at andrew.cazaeres@va.gov or (708) 786-4990 for further details.
    6505--Emtricitabine/Tenofovir Disoproxil Fumarate Tablets
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Emtricitabine 200mg/Tenofovir Disoproxil Fumarate 300mg Tablets, which will serve various federal health entities including the Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center. The contract aims to ensure an uninterrupted supply of this essential medication for a period of one year, with options for four additional one-year terms, emphasizing the VA's commitment to maintaining critical pharmaceutical supplies. The estimated annual requirement is approximately 91,583 bottles, and interested offerors must ensure their product has a unique National Drug Code (NDC) and complies with specific packaging requirements, including safety caps. The solicitation is expected to be issued electronically on or around April 26, 2025, with a response deadline of May 13, 2025; inquiries can be directed to Deb Fassl at Deborah.Fassl@va.gov.
    6505--Perphenazine Tablets (VA-25-00037353)
    Buyer not available
    The Department of Veterans Affairs (VA) is soliciting proposals for the procurement of Perphenazine tablets under solicitation number VA-25-00037353. This contract aims to supply specified quantities of the drug to both the VA and the Department of Defense (DoD) through their Pharmaceutical Prime Vendor (PPV) Programs, with a focus on service-disabled veteran-owned small businesses, women-owned small businesses, and HUBZone small businesses. The procurement is critical for ensuring a consistent supply of pharmaceutical products while adhering to regulatory requirements, including the Drug Supply Chain Security Act (DSCSA) and FDA Good Manufacturing Practices (cGMP). Interested offerors must contact Contract Specialist Anthony DiCrescenzo at Anthony.DiCrescenzo@va.gov for further details, and proposals must include a 0.5% Cost Recovery Fee and a unique National Drug Code (NDC) for each product.
    6505--Topiramate Tablets (VA-25-00047941)
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Topiramate Tablets, designated as Solicitation 36E79725R0031. This procurement aims to secure an uninterrupted supply of various forms of Topiramate for the VA, Department of Defense (DOD), Bureau of Prisons (BOP), and Indian Health Service (IHS), highlighting the importance of ensuring continuous access to essential pharmaceuticals across federal health services. The contract will span one year with four additional pre-priced option years, and interested vendors must submit their proposals electronically by April 29, 2025, while providing the exact name of the drug along with a unique National Drug Code (NDC). For further inquiries, vendors can contact Contract Specialist Billy Fong at billy.fong@va.gov or by phone at 708-786-4992.
    Q517--PND 06-30-2025- (North) - 436 - Omnicell 12 months of Advantage Support Services
    Buyer not available
    The Department of Veterans Affairs (VA) intends to award a sole source Fixed Price Indefinite Delivery/Indefinite Quantity (ID/IQ) contract to Omnicell, Inc. for the provision of preventative maintenance and support services for their medication supply systems. This contract will cover comprehensive support for 146 pieces of Omnicell equipment, including maintenance, emergency repairs, and software upgrades, ensuring compatibility with the VISTA inventory system and maintaining a 96% uptime for operational efficiency. The estimated period of performance for this contract is from July 1, 2025, to June 30, 2030, with responses due by May 9, 2025. Interested parties must submit their responses via email to Contract Specialist David Glanton at david.glanton@va.gov, and all contractors must be registered in the System for Award Management (SAM) by the response deadline.